Google DeepMind Launches TxGemma: Advancing AI-Driven Drug Discovery and Development

Google DeepMind has announced the launch of TxGemma, an open collection of AI models designed to enhance the efficiency of drug discovery and clinical trial predictions. Built on the Gemma model family, TxGemma aims to streamline the drug development process and accelerate the discovery of new treatments.

The development of new therapeutics is a slow, costly process that often faces a high rate of failure—90% of drug candidates do not progress past phase 1 trials. TxGemma seeks to…